申请人:Bhide Rajeev S.
公开号:US20100041636A1
公开(公告)日:2010-02-18
The present invention provides compounds of Formula (I), and pharmaceutically acceptable salts thereof. The Formula (I) compounds inhibit the tyrosine kinase activity of growth factor receptors such as VEGFR-2, FGFR-1 and IGFR-1, thereby making them useful as anti-cancer agents. The formula (I) compounds are also useful for the treatment of other diseases associated with signal transduction pathways operating through growth factor receptors.
本发明提供公式(I)的化合物及其药学上可接受的盐。公式(I)的化合物抑制生长因子受体的酪氨酸激酶活性,如VEGFR-2、FGFR-1和IGFR-1,因此使它们有用作抗癌剂。公式(I)的化合物也适用于治疗通过生长因子受体操作的信号转导途径所涉及的其他疾病。